Navigation Links
FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of the neuroimmune axis and its role in disease processes. The importance of the neuroimmune axis in disease pathophysiology and therapies will be discussed for benchmark nervous system disorders, such as multiple sclerosis and spinal cord injury.

In addition, emerging areas where the importance of the neuroimmune axis has only recently been recognized, such as neuropsychiatric disorders, lysosomal storage diseases and axonal regeneration will be discussed. This FASEB Conference brings together physician-scientists and basic scientists as well as postdoctoral and graduate trainees for presentations and one-on-one discussions to broaden our understanding of fundamental aspects of disease mechanisms and therapeutic strategies in a highly collaborative and collegial environment.

A new training component associated with this conference will include a one day pre-meeting course on neuroimmunology, with material crafted to coincide with the major scientific topics covered during the main meeting. The interdisciplinary nature of this conference arises from an understanding that neuroimmune processes are intimately linked to the pathophysiology of numerous nervous system disorders, and through understanding the cellular and molecular mechanisms of these pathologies, more effective therapies may be realized. The conference is attended by immunologists, neuroscientists, neuroimmunologists, physicians and physician-scientists and is the only long-standing specialized conference held in North America to regularly attract members from each of these related, but distinct disciplines.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
2. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
3. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
4. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
5. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
6. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
7. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
8. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
9. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
10. FASEB announces BioArt image and video competition winners
11. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps ... and North America this May on the following dates: , ?    London, ... Taylor, Chairman of the Learning and Performance Institute will be the opening ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, ... platform, has signed a collaborative and sponsored research ... Silvia Muro . The overall goal of ... pharmacodynamics of various 3DNA designs and formulations after ... targeting diseases of the vasculature as well as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... supplier of Common Lisp (CL) development tools, and market leader for Semantic ... key performance enhancements now available within the most effective system for developing and ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced TĀ·rejĀ·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
Breaking Biology Technology: